SA-2
Tuesday, April 7, 2026
24.9
C
Bengaluru
Hot topics
India’s Medical Devices Market: Strategic Implications and Key Investors
KKR's Investments in India's Medical Devices Market: Strategic Implications...
MedicinMan Steps into Year Five
Articles by K. Hariram, Daxesh Patel, Gopal Kishore, Amit Jain, Sunil Bajaj and Vivek Hattangadi
Inspirational Frontline Leadership
The last issue of 2016, with articles from K. Hariram and Vivek Hattangadi and new authors, Dr. Ashwin Bonde and Diksha Fouzdar. Diksha's article is the highlight of this issue - an in-depth look at how to embed compliance in the very DNA of a pharma company.
Eli Lilly’s Acquisition of Adverum Signals Focus on Gene Therapies to Redefine Eye Care
Eli Lilly’s planned acquisition of Adverum Biotechnologies is a...
Trump Tariff and the Trade Turbulence – A Salil Kallianpur BlogÂ
Impact of Trump’s 100% tariff on imported patented/innovative drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Hot topics
Pharma GCCs in India — Hype, Reality & What’s Next?
Part 1: Pharma GCCs in India — Orange Markets...
Rethinking Healthcare Communications for the Indian Context
Indian healthcare is sometimes an enigma: on one hand...
From VUCA to TACO: Thriving in a Chaotic World
From VUCA to TACO: Thriving in a Chaotic World
Leaders...
Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?
As over 50 generic versions of the blockbuster weight-loss...
Pharma and the Covid19 Crisis – An Interaction with Sunil Attavar, CMD, Group Pharma
This is the first part of MedicinMan interview series...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Newsletter
Get important news delivered directly to your inbox and stay connected!